Shanghai Pharmaceuticals Holding Co., Ltd

This study is testing whether adding an experimental drug called SPH4336 to standard hormone therapy can help control advanced breast cancer that has continued to grow despite prior treatment. It will involve about 254 adults with hormone-sensitive, HER2-negative breast cancer th…

This study is testing whether a new drug called SPH4336 works better alone or when combined with another drug, cadonilimab, for people with advanced solid tumors that can't be removed by surgery. The main goal is to see if the treatment can slow or stop cancer growth and is safe …

This early-stage study is testing a new drug called T3011 in people with advanced melanoma, a serious form of skin cancer. The main goals are to see if the treatment is safe and tolerable, and to get an early look at whether it can shrink tumors. The study will enroll about 42 pa…